Curcumin — The NF-κB Inhibitor
Curcumin is the principal bioactive polyphenol in turmeric (Curcuma longa), used in Ayurvedic medicine for millennia. It is one of the most studied anti-inflammatory compounds in the world, with over 3,000 published studies. Its primary limitation — extremely poor oral bioavailability (~1%) — has been addressed by modern formulations (Theracurmin, Meriva, BCM-95, NovaSol) that achieve 20–200× better absorption.
Mechanism of Action
Curcumin inhibits NF-κB (the master inflammatory transcription factor), reducing production of TNF-α, IL-1β, IL-6, and COX-2. It also activates Nrf2 (antioxidant response), inhibits mTOR, activates AMPK, and modulates SIRT1. It chelates heavy metals and inhibits amyloid-β aggregation, with potential Alzheimer's applications.
Human Trial Evidence
A 2014 Journal of Psychopharmacology RCT showed Theracurmin (90 mg bioavailable curcumin twice daily) significantly improved memory and attention in non-demented adults over 18 months and reduced amyloid/tau accumulation on PET scans. Multiple RCTs confirm reductions in CRP, IL-6, and joint pain in osteoarthritis.
Dosing Protocol
400–600 mg/day of standard curcumin extract requires piperine (black pepper) for absorption. Bioavailable formulations: Theracurmin 90 mg twice daily; Meriva 500 mg twice daily; BCM-95 500 mg/day. Always take with food. Piperine 5–20 mg increases standard curcumin absorption by 2,000%.
Safety & Contraindications
Well-tolerated. GI discomfort at high doses. Inhibits CYP3A4 and CYP2C9 — drug interactions with statins, blood thinners, chemotherapy. Mild anticoagulant effect — stop 2 weeks before surgery. Avoid in gallbladder disease (stimulates bile secretion). Avoid in pregnancy at high doses.